246 related articles for article (PubMed ID: 16386745)
1. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.
Li X; Chyu KY; Faria Neto JR; Yano J; Nathwani N; Ferreira C; Dimayuga PC; Cercek B; Kaul S; Shah PK
Circulation; 2004 Sep; 110(12):1701-5. PubMed ID: 15353488
[TBL] [Abstract][Full Text] [Related]
3. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.
Cesena FH; Dimayuga PC; Yano J; Zhao X; Kirzner J; Zhou J; Chan LF; Lio WM; Cercek B; Shah PK; Chyu KY
Atherosclerosis; 2012 Jan; 220(1):59-65. PubMed ID: 22062590
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM
Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylcholine-targeting immunization reduces atherosclerosis.
Caligiuri G; Khallou-Laschet J; Vandaele M; Gaston AT; Delignat S; Mandet C; Kohler HV; Kaveri SV; Nicoletti A
J Am Coll Cardiol; 2007 Aug; 50(6):540-6. PubMed ID: 17678738
[TBL] [Abstract][Full Text] [Related]
6. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
[TBL] [Abstract][Full Text] [Related]
7. Natural antibodies against phosphorylcholine in cardiovascular disease.
de Faire U; Frostegård J
Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
[TBL] [Abstract][Full Text] [Related]
8. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
[TBL] [Abstract][Full Text] [Related]
9. Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice.
Feng Y; Gordts SC; Chen F; Hu Y; Van Craeyveld E; Jacobs F; Carlier V; Feng Y; Zhang Z; Xu Q; Ni Y; De Geest B
Atherosclerosis; 2011 Feb; 214(2):271-8. PubMed ID: 20943224
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene.
Centa M; Gruber S; Nilsson D; Polyzos KA; Johansson DK; Hansson GK; Ketelhuth DF; Binder CJ; Malin S
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):25-36. PubMed ID: 26564818
[TBL] [Abstract][Full Text] [Related]
11. Passive immunization with hypochlorite-oxLDL specific antibodies reduces plaque volume in LDL receptor-deficient mice.
van Leeuwen M; Kemna MJ; de Winther MP; Boon L; Duijvestijn AM; Henatsch D; Bos NA; Gijbels MJ; Tervaert JW
PLoS One; 2013; 8(7):e68039. PubMed ID: 23874490
[TBL] [Abstract][Full Text] [Related]
12. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
[TBL] [Abstract][Full Text] [Related]
14. Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases.
de Vries MR; Ewing MM; de Jong RCM; MacArthur MR; Karper JC; Peters EAB; Nordzell M; Karabina SAP; Sexton D; Dahlbom I; Bergman A; Mitchell JR; Frostegård J; Kuiper J; Ninio E; Jukema JW; Pettersson K; Quax PHA
J Intern Med; 2021 Jul; 290(1):141-156. PubMed ID: 33342002
[TBL] [Abstract][Full Text] [Related]
15. Low levels of a natural IgM antibody are associated with vein graft stenosis and failure.
Sobel M; Moreno KI; Yagi M; Kohler TR; Tang GL; Clowes AW; Zhou XH; Eugenio E
J Vasc Surg; 2013 Oct; 58(4):997-1005.e1-2. PubMed ID: 23856610
[TBL] [Abstract][Full Text] [Related]
16. Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice.
Brito V; Mellal K; Portelance SG; Pérez A; Soto Y; deBlois D; Ong H; Marleau S; Vázquez AM
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2847-54. PubMed ID: 23087361
[TBL] [Abstract][Full Text] [Related]
17. Anti-phosphorylcholine IgM, an Anti-inflammatory Mediator, Predicts Peripheral Vein Graft Failure: A Prospective Observational Study.
Sobel M; Yagi M; Moreno K; Kohler TR; Tang GL; Wijelath ES; Marshall J; Kenagy RD
Eur J Vasc Endovasc Surg; 2019 Feb; 57(2):259-266. PubMed ID: 30343000
[TBL] [Abstract][Full Text] [Related]
18. Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice.
Chyu KY; Zhao X; Reyes OS; Babbidge SM; Dimayuga PC; Yano J; Cercek B; Fredrikson GN; Nilsson J; Shah PK
Biochem Biophys Res Commun; 2005 Dec; 338(4):1982-9. PubMed ID: 16288717
[TBL] [Abstract][Full Text] [Related]
19. Patients with polycystic ovary syndrome have lower levels of IgM anti-phosphorylcholine antibodies than healthy women.
Gingnell M; Dahlbom I; Lindholm A; Hudecova M; Arnadottir R; Hansson T; Sundstrom-Poromaa I
Gynecol Endocrinol; 2011 Jul; 27(7):486-90. PubMed ID: 20645890
[TBL] [Abstract][Full Text] [Related]
20. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen.
Nicoletti C
Exp Mol Pathol; 1995 Apr; 62(2):99-108. PubMed ID: 8549700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
